Literature DB >> 8844234

Inorganic fluoride concentration after long-term sedation with isoflurane.

M A Osborne1, J M Eddleston, W McNicoll.   

Abstract

We report on five patients in whom long-term sedation with isoflurane for up to 7 days was used successfully. Serum inorganic fluoride concentrations were measured daily. The concentrations ranged from 12 mmol l-1 to 29 mmol l-1. These were well below the described renal toxic level of 50 mmol l-1. There was no deterioration in renal function attributable to the use of isoflurane.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8844234     DOI: 10.1007/bf01709746

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  10 in total

1.  Definitions for sepsis and organ failure.

Authors:  R C Bone; C L Sprung; W J Sibbald
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

2.  Use of isoflurane for sedation in intensive care.

Authors:  F X Breheny; P A Kendall
Journal:  Crit Care Med       Date:  1992-07       Impact factor: 7.598

3.  Isoflurane compared with midazolam in the intensive care unit.

Authors:  S M Willatts; C Prys-Roberts; K L Kong; E M Spencer
Journal:  BMJ       Date:  1989-08-05

4.  Isoflurane compared with midazolam in the intensive care unit.

Authors:  G R Park; A M Burns
Journal:  BMJ       Date:  1989-06-17

5.  Sedation with isoflurane.

Authors:  A P Beechey; J M Hull; I McLellan; D W Atherley
Journal:  Anaesthesia       Date:  1988-05       Impact factor: 6.955

6.  Methoxyflurane nephrotoxicity. A study of dose response in man.

Authors:  M J Cousins; R I Mazze
Journal:  JAMA       Date:  1973-09-24       Impact factor: 56.272

7.  Serum fluoride analysis with the fluoride electrode.

Authors:  B W Fry; D R Taves
Journal:  J Lab Clin Med       Date:  1970-06

8.  Acute respiratory distress in adults.

Authors:  D G Ashbaugh; D B Bigelow; T L Petty; B E Levine
Journal:  Lancet       Date:  1967-08-12       Impact factor: 79.321

9.  Isoflurane compared with midazolam for sedation in the intensive care unit.

Authors:  K L Kong; S M Willatts; C Prys-Roberts
Journal:  BMJ       Date:  1989-05-13

10.  The use of propofol for sedation of critically ill patients undergoing haemodiafiltration.

Authors:  J M Eddleston; B J Pollard; J F Blades; B Doran
Journal:  Intensive Care Med       Date:  1995-04       Impact factor: 17.440

  10 in total
  3 in total

1.  [Sedation concepts with volatile anaesthetics in intensive care: practical use and current experiences with the AnaConDa system].

Authors:  J Kompardt; K Schärff; K Kubosch; C Pohl; M Bomplitz; J Soukup
Journal:  Anaesthesist       Date:  2008-12       Impact factor: 1.041

2.  Isoflurane for life-threatening bronchospasm: a 15-year single-center experience.

Authors:  David A Turner; David Heitz; Mehrengise K Cooper; P Brian Smith; John H Arnold; Scot T Bateman
Journal:  Respir Care       Date:  2012-03-13       Impact factor: 2.258

3.  The use of volatile anesthetic agents for long-term critical care sedation (VALTS): study protocol for a pilot randomized controlled trial.

Authors:  Angela Jerath; Niall D Ferguson; Andrew Steel; Duminda Wijeysundera; John Macdonald; Marcin Wasowicz
Journal:  Trials       Date:  2015-12-09       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.